home / stock / vblt / vblt news

VBLT News and Press, Vascular Biogenics Ltd. From 02/26/19

Stock Information
Company Name: Vascular Biogenics Ltd.
Stock Symbol: VBLT
Market: NASDAQ
Menu
VBLT VBLT Quote VBLT Short VBLT News VBLT Articles VBLT Message Board
Get VBLT Alerts

News, Short Squeeze, Breakout and More Instantly...
VBLT - VBL Presents New Data on the Potential of its Novel VB-600 Platform for Nonalcoholic Steatohepatitis (NASH) and Rheumatoid Arthritis (RA)

TEL AVIV, Israel, Feb. 26, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), (the “Company”) today announced new data implicating the potential of its VB-600 platform of antibodies targeting MOSPD2 (motile sperm domain-containing protein 2) for treatment of var...
VBLT - VBL Therapeutics Awarded $2.9 Million Non-Dilutive Grant by the Israel Innovation Authority

TEL AVIV, Israel, Feb. 20, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (the “Company”) today announced that it has been awarded a non-dilutive grant of over 10 million New Israeli Shekels (approximately $2.9 million) by the Israel Innovation Authority (IIA) for 20...

VBLT - VBL Therapeutics to Present Data on its Novel VB-600 Platform at Keystone Conference on February 26

TEL AVIV, Israel, Feb. 19, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), today announces that the Company will present new data on the potential of its VB-600 platform targeting MOSPD2 for inflammatory and oncology indications, at the Keystone Symposia on Myeloid Cells, to be ...

Previous 10 Next 10